Results 21 to 30 of about 681,060 (251)

Use of pharmacotherapies for treatment resistant depression in finland: A nationwide cohort study

European Psychiatry, 2021
Introduction There is a lack of knowledge on utilized pharmacotherapies for treatment resistant depression (TRD). Objectives To investigate the courses of treatment of TRD.
H. Taipale, M. Lähteenvuo, A. Tanskanen, S. Rannanpää, J. Tiihonen   +4 more
doaj   +1 more source

Patients’ Comprehension of Mindfulness-Based Cognitive Behavioral Therapy in an Outpatient Clinic for Resistant Depression: A Cross-Sectional Study

Frontiers in Psychology, 2019
The current study investigated the comprehension of mindfulness-based cognitive behavioral therapy (MBCT) by patients with resistant depression at the Psychiatry Institute of the Federal University of Rio de Janeiro, Brazil.
Michele F. Rodrigues, Carlos Campos, Luisa Pelucio, Izabel Barreto, Sergio Machado, Jose C. Appolinario, Antonio E. Nardi, Michelle Levitan   +7 more
doaj   +1 more source

Modeling treatment-resistant depression [PDF]

Neuropharmacology, 2011
Depression is a polygenic and highly complex psychiatric disorder that is currently a major burden on society. Depression is highly heterogeneous in presentation and frequently exhibits high comorbidity with other psychiatric and somatic disorders. Commonly used treatments, such as selective serotonin reuptake inhibitors (SSRIs), are not ideal since ...
Benjamin Adam, Samuels, Eduardo David, Leonardo, Reto, Gadient, Amanda, Williams, Jin, Zhou, Denis J, David, Alain Michel, Gardier, Erik H F, Wong, René, Hen   +8 more
openaire   +2 more sources

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.

PLoS ONE, 2020
ObjectiveThe economic burden of commercially insured patients in the United States with treatment-resistant depression and patients with non-treatment-resistant major depressive disorder was compared using data from the Optum Clinformatics™ claims ...
Gang Li, Ling Zhang, Allitia DiBernardo, Grace Wang, John J Sheehan, Kwan Lee, Johan Reutfors, Qiaoyi Zhang   +7 more
doaj   +2 more sources

Treatment-Resistant Depression in the Elderly

International Psychogeriatrics, 1995
Apparent treatment-resistant depression (TRD) is frequently encountered by and poses particular challenges for the old-age psychiatrist. The prevalence of true nonresponse to treatment is not known with accuracy but reports put it at 18% to 40% for the elderly.
D, Bonner, R, Howard
openaire   +2 more sources

A study of remitted and treatment-resistant depression using MMPI and including pessimism and optimism scales. [PDF]

PLoS ONE, 2014
The psychological aspects of treatment-resistant and remitted depression are not well documented.We administered the Minnesota Multiphasic Personality Inventory (MMPI) to patients with treatment-resistant depression (n = 34), remitted depression (n = 25),
Masatoshi Suzuki, Michio Takahashi, Katsumasa Muneoka, Koichi Sato, Kenji Hashimoto, Yukihiko Shirayama   +5 more
doaj   +1 more source

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression

Bipolar Disorders, 2023
Bipolar depression accounts for most of the disease duration in type I and type II bipolar disorder (BD), with few treatment options, often poorly tolerated.
G. Martinotti, B. Dell’Osso, G. Di Lorenzo, G. Maina, A. Bertolino, M. Clerici, S. Barlati, G. Rosso, M. Di Nicola, M. Marcatili, G. d’Andrea, C. Cavallotto, Stefania Chiappini, S. De Filippis, G. Nicolò, P. De Fazio, I. Andriola, R. Zanardi, D. Nucifora, S. Di Mauro, R. Bassetti, M. Pettorruso, R. McIntyre, S. Sensi, M. Di Giannantonio, A. Vita   +25 more
semanticscholar   +1 more source

Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression

Pharmaceuticals, 2023
Treatment-resistant depression (TRD) is a term used to describe a particular type of major depressive disorder (MDD). There is no consensus about what defines TRD, with various studies describing between 1 and 4 failures of antidepressant therapies, with
Courtney M. Vecera, Alan C. Courtes, Gregory Jones, Jair C. Soares, Rodrigo Machado-Vieira   +4 more
doaj   +1 more source

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

Lancet psychiatry, 2016
BACKGROUND Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive ...
R. Carhart-Harris, M. Bolstridge, J. Rucker, Camilla M. Day, D. Erritzoe, M. Kaelen, M. Bloomfield, J. Rickard, Ben Forbes, A. Feilding, David Taylor, S. Pilling, V. Curran, D. Nutt   +13 more
semanticscholar   +1 more source

Do baseline anxiety symptoms impact response to IV Ketamine in treatment resistant depression?

Journal of Affective Disorders Reports, 2021
Objective: In a retrospective study, we analyzed if anxious depression impacts outcomes in patients with treatment resistant depression (TRD) receiving IV Ketamine infusions at an academic center Ketamine clinic.
Zoe Schreiber, Chenyang Wang, Amanda Tan, Patricio Riva-Posse, William M. McDonald, Andrea Crowell, Adriana P. Hermida, Rachel Hershenberg   +7 more
doaj   +1 more source